Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - irbesartan, quantity: 75 mg - tablet, film coated - excipient ingredients: hypromellose; magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; croscarmellose sodium; lactose monohydrate; titanium dioxide; macrogol 4000 - - indicated for the treatment of hypertension.,- indicated for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (greater than or equal to 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - irbesartan, quantity: 150 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; croscarmellose sodium; hypromellose; colloidal anhydrous silica; titanium dioxide; macrogol 4000 - - indicated for the treatment of hypertension.,- indicated for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (greater than or equal to 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - irbesartan, quantity: 150 mg - tablet, film coated - excipient ingredients: magnesium stearate; croscarmellose sodium; colloidal anhydrous silica; hypromellose; lactose monohydrate; microcrystalline cellulose; titanium dioxide; macrogol 4000 - - indicated for the treatment of hypertension.,- indicated for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (greater than or equal to 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - irbesartan, quantity: 75 mg - tablet, film coated - excipient ingredients: hypromellose; lactose monohydrate; croscarmellose sodium; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; macrogol 4000 - - indicated for the treatment of hypertension.,- indicated for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (greater than or equal to 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - irbesartan, quantity: 300 mg - tablet, film coated - excipient ingredients: carnauba wax; magnesium stearate; croscarmellose sodium; lactose monohydrate; silicon dioxide; microcrystalline cellulose; hypromellose; titanium dioxide; macrogol 3000 - avapro is indicated for the treatment of hypertension. avapro is indicated for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (equal to or greater than 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - irbesartan, quantity: 300 mg - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; croscarmellose sodium; lactose monohydrate; silicon dioxide; carnauba wax; hypromellose; titanium dioxide; macrogol 3000 - karvea is indicated for the treatment of hypertension. karvea is indicated for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (more than or equal to 30 mg per 24 hour) or urinary protein in excess of 900 mg per 24 hours

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - irbesartan, quantity: 300 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; croscarmellose sodium; magnesium stearate; iron oxide yellow; microcrystalline cellulose; hypromellose; colloidal anhydrous silica; titanium dioxide; purified talc; macrogol 4000; macrogol 400 - indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - irbesartan, quantity: 300 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: magnesium stearate; povidone; croscarmellose sodium; lactose monohydrate; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 4000 - for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - hydrochlorothiazide, quantity: 25 mg; irbesartan, quantity: 300 mg - tablet, film coated - excipient ingredients: povidone; magnesium stearate; lactose monohydrate; croscarmellose sodium; iron oxide yellow; iron oxide red; titanium dioxide; hypromellose; macrogol 4000; iron oxide black - for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - irbesartan, quantity: 150 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: polysorbate 80; sodium starch glycollate type b; colloidal anhydrous silica; mannitol; hypromellose; povidone; magnesium stearate; titanium dioxide; iron oxide yellow; iron oxide red; carnauba wax; macrogol 3350 - indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.